Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

200,450 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
An androgen receptor N-terminal domain antagonist for treating prostate cancer.
Myung JK, Banuelos CA, Fernandez JG, Mawji NR, Wang J, Tien AH, Yang YC, Tavakoli I, Haile S, Watt K, McEwan IJ, Plymate S, Andersen RJ, Sadar MD. Myung JK, et al. Among authors: wang j. J Clin Invest. 2013 Jul;123(7):2948-60. doi: 10.1172/JCI66398. Epub 2013 Jun 3. J Clin Invest. 2013. PMID: 23722902 Free PMC article.
Androgen receptor decoy molecules block the growth of prostate cancer.
Quayle SN, Mawji NR, Wang J, Sadar MD. Quayle SN, et al. Among authors: wang j. Proc Natl Acad Sci U S A. 2007 Jan 23;104(4):1331-6. doi: 10.1073/pnas.0606718104. Epub 2007 Jan 16. Proc Natl Acad Sci U S A. 2007. PMID: 17227854 Free PMC article.
Spongian diterpenoids inhibit androgen receptor activity.
Yang YC, Meimetis LG, Tien AH, Mawji NR, Carr G, Wang J, Andersen RJ, Sadar MD. Yang YC, et al. Among authors: wang j. Mol Cancer Ther. 2013 May;12(5):621-31. doi: 10.1158/1535-7163.MCT-12-0978. Epub 2013 Feb 26. Mol Cancer Ther. 2013. PMID: 23443807 Free PMC article.
200,450 results
You have reached the last available page of results. Please see the User Guide for more information.